AntibioticMech

Browse · ANTIBACTERIAL

fidaxomicin

CHEBI:68590 ·resolve ·ANTIBACTERIAL ·EXACT REVIEWED

An 18-membered macrolide that is a fermentation product obtained from the Actinomycete Dactylosporangium aurantiacum. A narrow spectrum antibiotic used for treatment of Clostridium difficile-related infections. — ChEBI

Classification

macrocyclic antibioticARO:3001318

Strictly broader compounds or drug classes this molecule belongs to.

Chemical structure

Computed structure properties
Molecular formulaC52H74Cl2O18
Charge0
Average mass1058.052 Da
Monoisotopic mass1056.42522 Da
SourceChEBI
InChIKeyZVGNESXIJDCBKN-KFGPIHIUSA-N

SMILES

CCc1c(Cl)c(O)c(Cl)c(O)c1C(=O)O[C@H]1[C@H](O)[C@H](OC)[C@H](OC/C2=C\C=C\C[C@H](O)/C(C)=C/[C@H](CC)[C@@H](O[C@@H]3OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]3O)/C(C)=C/C(C)=C/CC([C@@H](C)O)OC2=O)O[C@@H]1C

InChI

InChI=1S/C52H74Cl2O18/c1-13-30-22-26(6)33(56)18-16-15-17-31(23-66-51-45(65-12)42(61)44(29(9)67-51)69-49(64)35-32(14-2)36(53)39(58)37(54)38(35)57)48(63)68-34(28(8)55)20-19-25(5)21-27(7)43(30)70-50-41(60)40(59)46(52(10,11)72-50)71-47(62)24(3)4/h15-17,19,21-22,24,28-30,33-34,40-46,50-51,55-61H,13-14,18,20,23H2,1-12H3/b16-15+,25-19+,26-22+,27-21+,31-17+/t28-,29-,30+,33+,34?,40-,41+,42+,43+,44-,45+,46+,50-,51-/m1/s1

Also called

Cross-references

Identifiers for this same structure in other resources. An accession that lands on two different structures in this corpus is withheld from both rather than shown here, since it names at most one of them.

Drug registries

Identifiers that name a drug rather than a structure. One of these can cover a parent compound, its salts and its stereoisomers, which this corpus keeps as separate records, so it is not an equivalence of structure.

Patents and articles

Documents about this compound. A patent covers a class and an article covers a topic; neither identifies a structure.

Activity roles

Every antimicrobial role a source asserts for this compound — the unreduced evidence behind its antimicrobial_class.

Source concepts

Every upstream concept that resolved to this record. The merge is the product: this is what shows ChEBI and CARD are describing the same structure.

Upstream concepts merged into this record
SourceNative IDLabelMinted CURIEVersion
ARO ARO:3001319 fidaxomicin antibioticmech:aro-1169c528a5 2026-08-30
CHEBI CHEBI:68590 fidaxomicin antibioticmech:chebi-ff9b90ceb4 2026-08-30

Molecular targets

The molecular entity or process this compound acts on. Each target carries evidence — this is a mechanistic claim, not a classification.

antibiotic sensitive RNA polymerase switch region PROTEIN_COMPLEX DIRECT_BINDING_TARGET

ARO:3003439

CARD/ARO database assertion; target organism, strain, and assay are not specified. The RNA polymerase switch region is asserted as the target site. Evidence status: PRIMARY_EVIDENCE_NEEDED. Source: CARD_ARO 2026-08-30 (retrieved 2026-08-30).

bacterial RNA polymerase PROTEIN_COMPLEX DIRECT_BINDING_TARGET

A cryo-EM structure directly observed fidaxomicin bound to C. difficile RNA polymerase; biochemical and genetic tests identified a residue that sensitizes the enzyme and contributes to narrow-spectrum activity. Evidence status: PRIMARY_EVIDENCE. Source: PRIMARY_LITERATURE 2022-04 (retrieved 2026-09-02).

Clostridioides difficile NCBITaxon:1496

Organism-specific examples
ProteinGeneOrganismEntry
DNA-directed RNA polymerase subunit beta UniProtKB:Q18CF4
RNA polymerase beta subunit forming part of the fidaxomicin-binding clamp cleft in the C. difficile cryo-EM complex (PMID:35388215, PDB 7L7B; strain 630 reference proteome context).
rpoB Clostridioides difficile (strain 630) NCBITaxon:272563 REVIEWED
DNA-directed RNA polymerase subunit beta' UniProtKB:Q18CF3
RNA polymerase beta' subunit contributing the lineage-specific fidaxomicin-sensitizing residue in the C. difficile cryo-EM complex (PMID:35388215, PDB 7L7B; strain 630 reference proteome context).
rpoC Clostridioides difficile (strain 630) NCBITaxon:272563 REVIEWED

Mechanism summary

Mode of action
NUCLEIC_ACID_SYNTHESIS_INHIBITION host shared target — CURATOR: PMID:35388215 resolved fidaxomicin bound to Clostridioides difficile RNA polymerase and combined structural, biochemical, genetic, and bioinformatic evidence to identify a single sensitizing residue absent from many gut commensals. These data support bacterial transcription inhibition and explain an important determinant of narrow-spectrum activity.

Record-level evidence

Curation history

  1. SEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Seeded from data/raw/ inventories (ARO, CHEBI)

  2. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  3. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  4. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  5. REVIEWED 2026-09-03 · codex · LLM-assisted

    Verified exact ChEBI/CARD identity, structure, antibacterial role, class, FDA provenance, and retained CARD target assertion; curator-confirmed transcription inhibition and added the directly bound C. difficile RNAP complex.

  6. RESEEDED_FROM_SOURCES 2026-09-10 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  7. CURATED_UNIPROT_PROTEIN_EXAMPLES 2026-10-18 · antigravity · LLM-assisted

    Added curated Clostridioides difficile strain 630 RpoB (Q18CF4) and RpoC (Q18CF3) UniProtKB protein examples on the PRIMARY_LITERATURE bacterial RNA polymerase molecular target.

Provenance

Seeded by scripts/seed_from_sources.py from the committed inventories in data/raw/. View the record (YAML).

Explore across X-Mech: MediaIngredientMech (fidaxomicin) · CultureMech · NaturalProductMech · PathwayMech · TraitMech